GlassScriptPhysician profile
Syed Jafar Raza
NPI 1275609588
$760.94
in general payments reported to CMS, 2019-2025
15 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $31.67 · 2021: $11.22 · 2023: $68.80 · 2024: $147 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.48 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $231.71 | 2019 | |
| Medtronic, INC. | $130.03 | 2024-2025 | Micra, Azure Xt Dr Mri Surescan, Linq II |
| Abiomed | $114.95 | 2019-2020 | |
| Cvrx, INC. | $42.50 | 2023 | Barostim Neo System |
| Kyowa Kirin, INC. | $37.15 | 2025 | |
| Novo Nordisk INC | $32.27 | 2024 | Wegovy |
| Tactile Systems Technology INC | $31.88 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Stryker Corporation | $29.20 | 2025 | Flowtriever |
| Emd Serono, INC. | $23.76 | 2025 | |
| Abbott Laboratories | $21.43 | 2024 | Coroflow |
| Sanofi-Aventis U.S. LLC | $15.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.80 | 2020 | |
| Teleflex LLC | $13.53 | 2023 | Vascband |
| Chiesi USA, INC. | $11.22 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.